MA53626A - Procédés non hormonaux de contraception masculine - Google Patents

Procédés non hormonaux de contraception masculine

Info

Publication number
MA53626A
MA53626A MA053626A MA53626A MA53626A MA 53626 A MA53626 A MA 53626A MA 053626 A MA053626 A MA 053626A MA 53626 A MA53626 A MA 53626A MA 53626 A MA53626 A MA 53626A
Authority
MA
Morocco
Prior art keywords
male contraception
hormonal method
hormonal
contraception
male
Prior art date
Application number
MA053626A
Other languages
English (en)
Other versions
MA53626B1 (fr
Inventor
Véronique Agathon-Meriau
Stéphane Droupy
Glaoui Guillaume El
Glaoui Mehdi El
Philippe Perrin
Original Assignee
Laboratoires Major
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Major filed Critical Laboratoires Major
Publication of MA53626A publication Critical patent/MA53626A/fr
Publication of MA53626B1 publication Critical patent/MA53626B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
MA53626A 2018-03-23 2019-03-22 Procédés non hormonaux de contraception masculine avec (r)-silodosin MA53626B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862763129P 2018-03-23 2018-03-23
EP18305328 2018-03-23
EP20182691.4A EP3750538B1 (fr) 2018-03-23 2019-03-22 Procédés non hormonaux de contraception masculine avec (r)-silodosin

Publications (2)

Publication Number Publication Date
MA53626A true MA53626A (fr) 2022-03-09
MA53626B1 MA53626B1 (fr) 2024-09-30

Family

ID=65955198

Family Applications (1)

Application Number Title Priority Date Filing Date
MA53626A MA53626B1 (fr) 2018-03-23 2019-03-22 Procédés non hormonaux de contraception masculine avec (r)-silodosin

Country Status (19)

Country Link
US (3) US10912762B2 (fr)
EP (2) EP3750538B1 (fr)
JP (1) JP7270901B2 (fr)
KR (1) KR102496504B1 (fr)
CN (1) CN112074269A (fr)
AU (1) AU2019237228B2 (fr)
BR (1) BR112020018925A2 (fr)
CA (1) CA3094016C (fr)
DK (2) DK3562485T3 (fr)
ES (2) ES2989170T3 (fr)
FI (1) FI3750538T3 (fr)
IL (1) IL277372B2 (fr)
MA (1) MA53626B1 (fr)
MX (1) MX2020009937A (fr)
PL (2) PL3562485T3 (fr)
PT (1) PT3562485T (fr)
SG (1) SG11202008794TA (fr)
UA (1) UA128502C2 (fr)
WO (1) WO2019180217A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3750538B1 (fr) * 2018-03-23 2024-08-14 Pharmajor International Procédés non hormonaux de contraception masculine avec (r)-silodosin
IL319287A (en) 2022-11-23 2025-04-01 Pharmajor Incorporated Silodosin formulations with different release and their use in male contraceptive methods

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1091276A (en) 1911-12-09 1914-03-24 Basf Ag Producing unsaturated terpene hydrocarbons.
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
DE4308406C1 (de) 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
ATE474580T1 (de) 2000-02-15 2010-08-15 Bayer Schering Pharma Ag Zusammensetzung zur männlichen kontrazeption, norethisteron enthaltend
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
UA95085C2 (ru) * 2005-09-29 2011-07-11 Баер Шеринг Фарма Акциенгезельшафт Применение варденафила для лечения урологических расстройств
JP2009509984A (ja) * 2005-09-29 2009-03-12 バイエル・ヘルスケア・アクチェンゲゼルシャフト 泌尿器系障害の処置用のｐｄｅ阻害剤およびそれらの組合せ
US20100098735A1 (en) * 2006-10-05 2010-04-22 Rajesh Jain Injectable depot compositions and its process of preparation
GB0700893D0 (en) 2007-01-17 2007-02-21 King S College London Male contraceptive
MX2009009230A (es) 2007-02-28 2009-11-26 Kissei Pharmaceutical Uso de silodosina en una administracion diaria para tratar hiperplasia prostatica benigna.
US20120184591A1 (en) * 2011-01-13 2012-07-19 Watson Pharmaceuticals, Inc. Methods for treating prostatitis
CN102283816B (zh) * 2011-08-05 2013-09-11 北京海步国际医药科技发展有限公司 西洛多辛缓释片剂及其制备方法
WO2014118606A2 (fr) * 2013-01-29 2014-08-07 Alembic Pharmaceuticals Limited Nouveau procédé de préparation de silodosine
WO2016051782A1 (fr) 2014-09-30 2016-04-07 キッセイ薬品工業株式会社 Préparation pour voie orale dans laquelle le goût amer d'un médicament au goût amer est masqué
US20170049834A1 (en) * 2015-08-18 2017-02-23 Golden Biotechnology Corporation Benign prostatic hyperplasia add-on therapy
EP3750538B1 (fr) * 2018-03-23 2024-08-14 Pharmajor International Procédés non hormonaux de contraception masculine avec (r)-silodosin

Also Published As

Publication number Publication date
AU2019237228B2 (en) 2023-06-08
US10912762B2 (en) 2021-02-09
US11583518B2 (en) 2023-02-21
US20210113526A1 (en) 2021-04-22
NZ767741A (en) 2024-11-29
MX2020009937A (es) 2022-09-30
US11951095B2 (en) 2024-04-09
EP3562485A1 (fr) 2019-11-06
RU2020134408A3 (fr) 2022-04-29
ES2989170T3 (es) 2024-11-25
JP7270901B2 (ja) 2023-05-11
US20230145374A1 (en) 2023-05-11
IL277372B1 (en) 2023-05-01
EP3562485B8 (fr) 2020-08-19
PT3562485T (pt) 2020-08-27
BR112020018925A2 (pt) 2020-12-29
SG11202008794TA (en) 2020-10-29
RU2020134408A (ru) 2022-04-29
FI3750538T3 (fi) 2024-09-24
EP3750538B1 (fr) 2024-08-14
ES2813084T3 (es) 2021-03-22
AU2019237228A1 (en) 2020-10-01
CA3094016C (fr) 2023-10-10
DK3562485T3 (da) 2020-08-24
EP3750538A1 (fr) 2020-12-16
PL3750538T3 (pl) 2024-11-25
KR102496504B1 (ko) 2023-02-06
MA53626B1 (fr) 2024-09-30
WO2019180217A1 (fr) 2019-09-26
UA128502C2 (uk) 2024-07-31
IL277372B2 (en) 2023-09-01
KR20200135978A (ko) 2020-12-04
CA3094016A1 (fr) 2019-09-26
CN112074269A (zh) 2020-12-11
JP2021518438A (ja) 2021-08-02
IL277372A (en) 2020-11-30
PL3562485T3 (pl) 2020-11-16
DK3750538T3 (da) 2024-09-23
EP3562485B1 (fr) 2020-07-01
US20190290615A1 (en) 2019-09-26

Similar Documents

Publication Publication Date Title
MA50205A (fr) Formulation de nicotine
DK3661921T3 (da) Selektive hæmmere af nlrp3-inflammasom
PL3810683T3 (pl) Sposób oczyszczania odzyskiwanego polietylenu
MA42406A (fr) Mise en place de shunt intraoculaire ab externo
PT3790874T (pt) Derivados de quinolina antelmínticos
EP3878007A4 (fr) Formation de réseaux inclinés
EP3827689A4 (fr) Première de propreté
PT3457851T (pt) Derivados de sobetiroma
DK3533449T3 (da) SELEKTIV HÆMMER AF EXON-20-INSERTIONsMUTANT EGFR
EP3302356A4 (fr) Déploiement de prothèse endoluminale assisté par ballonnet
EP3899645A4 (fr) Procédé de formation de réseaux
DK3325482T3 (da) Fremgangsmåder til fremstilling af cytotoksiske benzodiazepinderivater
EP3608576A4 (fr) Nouveau type de joint de tuyau rapide
EP3470546A4 (fr) Procédé de formation de film
DK3266723T3 (da) Hus til fordeling af rør til cigaretter
EP3706161A4 (fr) Joint brasé et procédé de formation de joint brasé
IL268213A (en) Methods of preparing cytotoxic benzodiazepine derivatives
EP3448375A4 (fr) Dérivés de benzoylglycine et procédés de production et d'utilisation de ces dérivés
MA53626A (fr) Procédés non hormonaux de contraception masculine
FR25C1050I1 (fr) Dérivés de mmf d'éthylèneglycols
HUE055374T2 (hu) Eljárás Lenvatinib elõállítására
DK3500572T3 (da) Cytisinderivater til behandling af afhængighed
EP3472130A4 (fr) Dérivés de prolinamide aliphatique
EP3802627A4 (fr) Procédés de préparation de sugammadex
ES1209943Y (es) Protector de ropa interior masculina